Genomic expression profiles of blood and placenta reveal significant immune-related pathways and categories in Chinese women with gestational diabetes mellitus

Diabetic Medicine

Volumn 28, Issue 2, 2011, Pages 237-246

  Zhao, Y H ^a   Wang, D P ^b,c   Zhang, L L ^b,c   Zhang, F ^b   Wang, D M ^b   Zhang, W Y ^d  

^a JILIN UNIVERSITY   (China)

^b Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Blood; Gestational diabetes mellitus; Immune related; Microarray; Placenta

Indexed keywords

CD48 ANTIGEN; GAMMA INTERFERON; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HLA G ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 1BETA; LEPTIN; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN VAV3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA SEQUENCE; DOWN REGULATION; ETHNICITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; NATURAL KILLER CELL; PREGNANCY DIABETES MELLITUS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES, GESTATIONAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; PLACENTA; PREGNANCY; PROTEIN ARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78651108783     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03140.x     Document Type: Article

References (38)

1. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999; 341: 1749-1756.
2. Jarvela IY, Juutinen J, Koskela P, Hartikainen AL, Kulmala P, Knip M et al. Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care 2006; 29: 607-612.
3. Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91: 4137-4143.
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27: S5-S10.
5. Yang X, Hsu-Hage B, Zhang H, Yu L, Dong L, Li J et al. Gestational diabetes mellitus in women of single gravidity in Tianjin City, China. Diabetes Care 2002; 25: 847-851.
6. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003; 52: 2951-2958.
7. Enquobahrie DA, Williams MA, Qiu C, Meller M, Sorensen TK. Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol 2009; 200: 206.e1-206.e13.
8. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547-1548.
9. de Hoon MJ, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics 2004; 20: 1453-1454.
10. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29: 365-371.
11. Zheng Q, Wang XJ. GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res 2008; 36: W358-363.
12. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C et al. A systems biology approach for pathway level analysis. Genome Res 2007; 17: 1537-1545.
13. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13: 2498-2504.
14. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30: e15.
15. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielser HB, et al. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 2002; 3: research0048-research0048.16.
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Methodol 1995; 57: 289-300.
17. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008; 36: D480-484.
18. Lenk GM, Tromp G, Weinsheimer S, Gatalica Z, Berguer R, Kuivaniemi H. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 2007; 8: 237.
19. Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999; 19: 2435-2444.
20. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29.
21. Oztekin O. New insights into the pathophysiology of gestational diabetes mellitus: possible role of human leukocyte antigen-G. Med Hypotheses 2007; 69: 526-530.
22. Thomson AW, Lotze MT. The Cytokine Handbook. San Diego: Academic Press, 2003.
23. Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 2007; 30: S120-126.
24. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004; 30: 13-19.
25. Hauguel-de Mouzon S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta 2006; 27: 794-798.
26. Upshaw JL, Leibson PJ. NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes. Semin Immunol 2006; 18: 167-175.
27. Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H et al. Activation of NK cell cytotoxicity. Mol Immunol 2005; 42: 501-510.
28. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796-2803.
29. Mauricio D, de Leiva A. Autoimmune gestational diabetes mellitus: a distinct clinical entity? Diabetes Metab Res Rev 2001; 17: 422-428.
30. de Leiva A, Mauricio D, Corcoy R. Diabetes-related autoantibodies and gestational diabetes. Diabetes Care 2007; 30: S127-133.
31. Dotta F, Fondelli C, Falorni A. Can NK cells be a therapeutic target in human type 1 diabetes? Eur J Immunol 2008; 38: 2961-2963.
32. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003; 133: 1674S-1683S.
33. Elo LL, Mykkanen J, Nikula T, Jarvenpaa H, Simell S, Aittokallio T et al. Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling. J Autoimmun 2010; 35: 70-76.
34. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 2007; 92: 3705-3711.
35. Palsgaard J, Brons C, Friedrichsen M, Dominguez H, Jensen M, Storgaard H et al. Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways. PLoS One 2009; 4: e6575.
36. Das UN, Rao AA. Gene expression profile in obesity and type 2 diabetes mellitus. Lipids Health Dis 2007; 6: 35.
37. Takamura T, Sakurai M, Ota T, Ando H, Honda M, Kaneko S. Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients. Diabetologia 2004; 47: 638-647.
38. Wang X, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner MJ. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol 2008; 180: 1929-1937.